ACCOLADE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.89 USD | -14.15% |
|
-13.58% | -34.30% |
| 26/04 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
| 25/04 | Transcript : Accolade, Inc., Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACCOLADE, INC. | Other Healthcare Facilities & Services | -14.15% | -13.58% | -34.30% | -50.87% | - | 618M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACCD Stock
- Charts Accolade, Inc.
- Comparison Chart
